not tagged
astrazeneca
['ovarian', 'triplet,(-triplete)', 'astrazeneca']
at the ongoing conference, presented updated clinical profiles of its triplet regimen versus the doublet regimen in an ovarian cancer subgroup. get a detailed analysis at: #esmo2022 #esmo #esmo22 #breakthroughs #abstracts #oncology 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry